PaxMedica (NASDAQ:PXMD) Trading Down 3.6%

PaxMedica, Inc. (NASDAQ:PXMDGet Rating)’s share price fell 3.6% during mid-day trading on Tuesday . The stock traded as low as $2.30 and last traded at $2.38. 190,469 shares were traded during trading, a decline of 24% from the average session volume of 251,516 shares. The stock had previously closed at $2.47.

PaxMedica Stock Down 3.6 %

The company’s fifty day moving average price is $1.98.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in PaxMedica stock. Jane Street Group LLC acquired a new stake in PaxMedica, Inc. (NASDAQ:PXMDGet Rating) during the third quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 18,025 shares of the company’s stock, valued at approximately $43,000. Jane Street Group LLC owned approximately 0.15% of PaxMedica as of its most recent filing with the SEC.

PaxMedica Company Profile

(Get Rating)

PaxMedica, Inc, a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human African trypanosomiasis (HAT).

Featured Articles

Receive News & Ratings for PaxMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PaxMedica and related companies with MarketBeat.com's FREE daily email newsletter.